Cephadex is a branded form of cephalexin, a first‑generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It works by disrupting bacterial cell wall synthesis, making it effective against common pathogens that cause strep throat, skin and soft tissue infections, ear infections, and uncomplicated urinary tract infections. Available as capsules and oral suspension, Cephadex is generally well-tolerated when taken as directed. It is not effective for viral illnesses like colds or flu. Appropriate dosing, adherence to the full course, and antibiotic stewardship are essential to preserve effectiveness and reduce resistance.
Cephadex is commonly prescribed to treat bacterial infections caused by susceptible organisms, including Streptococcus pyogenes (strep throat), methicillin-sensitive Staphylococcus aureus (skin and soft tissue infections such as cellulitis and impetigo), and certain Gram-negative bacteria like Escherichia coli and Klebsiella pneumoniae (uncomplicated urinary tract infections). It can also be used in selected cases of otitis media and bone infections when organisms are susceptible. As a bactericidal beta‑lactam antibiotic, cephalexin impairs bacterial cell wall synthesis, leading to cell death and clinical improvement when used appropriately.
Antibiotic selection should be guided by local resistance patterns and, when available, culture and susceptibility results. Cephadex is not active against most MRSA, Pseudomonas, Enterococcus, or atypical organisms. It does not treat viral infections (e.g., colds, influenza, COVID‑19). To reduce antibiotic resistance and recurrence, use only for confirmed or strongly suspected bacterial infections and complete the full course as directed by your healthcare professional.
Adults: Typical dosing is 250 mg every 6 hours or 500 mg every 12 hours, with total daily doses generally ranging from 1 to 4 grams depending on infection severity and site. Common regimens include 500 mg twice daily for uncomplicated skin infections or strep pharyngitis (often for 7–10 days, with 10 days preferred for streptococcal pharyngitis), and 500 mg every 12 hours or 250 mg every 6 hours for uncomplicated UTIs. Severe infections may require higher total daily doses within the approved range. Always follow prescriber instructions individualized to your case.
Pediatrics: Usual dosing is 25–50 mg/kg/day divided every 12 hours or every 6 hours, not to exceed 4 g/day. For more severe infections, 50–100 mg/kg/day may be used under medical supervision. Accurate weight‑based dosing and a calibrated oral syringe or dosing spoon are essential for suspension. In all age groups, therapy duration is tailored to infection type and clinical response.
Administration: Cephadex may be taken with or without food; taking with food can reduce gastrointestinal upset. Swallow capsules whole and shake oral suspension well before each dose. Measure liquid doses with a dosing syringe rather than household spoons to ensure accuracy. If your prescriber obtained culture results, do not stop early even if you feel better—complete the full course to prevent relapse and resistance.
Allergies: Do not take cephalexin if you have a known serious hypersensitivity to cephalosporins. Exercise caution if you have a history of immediate, severe reactions to penicillins (e.g., anaphylaxis) due to potential cross‑reactivity. Seek urgent care if you develop signs of a serious allergic reaction such as hives, facial or throat swelling, wheezing, or difficulty breathing.
Medical conditions: Tell your clinician if you have kidney disease, a history of gastrointestinal disease (especially colitis), or if you are pregnant or breastfeeding. Cephalexin is generally considered compatible with pregnancy and lactation, but individual risk–benefit assessment is important. For renal impairment, dose adjustments or extended dosing intervals are often required to prevent drug accumulation and reduce seizure risk. Prolonged or repeated use may increase the risk of Clostridioides difficile–associated diarrhea—seek care for severe, persistent, or bloody diarrhea during or after therapy.
Cephadex is contraindicated in patients with a known hypersensitivity to cephalexin or other cephalosporin antibiotics. Use with caution in those with a history of immediate, severe reactions to penicillins or other beta‑lactams. Additional cautions include significant renal impairment without appropriate dose adjustment and prior severe antibiotic‑associated colitis. If you are unsure whether Cephadex is appropriate, consult a licensed clinician before use.
Common side effects include gastrointestinal upset (nausea, vomiting, abdominal discomfort), diarrhea, and headache. Mild rash or itching may occur. Some people may develop vaginal yeast infections or oral thrush due to changes in normal flora. Most effects are self‑limited and improve after completing therapy or with supportive care. Taking doses with food and staying hydrated can help minimize stomach symptoms.
Serious but less common adverse effects include severe allergic reactions, C. difficile–associated diarrhea (watery or bloody stools, abdominal cramps, fever), severe skin reactions (e.g., Stevens–Johnson syndrome), seizures (usually in the setting of high levels and renal impairment), liver enzyme elevations, blood dyscrasias, and interstitial nephritis. Stop the medication and seek medical attention if you experience severe rash, jaundice, dark urine, unusual bruising/bleeding, confusion, or persistent severe diarrhea.
Probenecid can increase cephalexin blood levels by reducing renal tubular secretion. Concomitant use with warfarin and other anticoagulants may increase INR in some patients; monitor as directed. Cephalexin may increase metformin exposure—observe for gastrointestinal intolerance or hypoglycemia and follow your prescriber’s guidance. Live oral typhoid and cholera vaccines may be less effective if given during antibiotic therapy. Laboratory interactions can include false‑positive urine glucose with copper reduction tests and positive direct Coombs’ tests. Always provide your clinician and pharmacist a complete list of medications, supplements, and vaccines.
If you miss a dose of Cephadex, take it as soon as you remember unless it is close to the time for your next dose. If it is near the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up. Keeping a dosing reminder on your phone can help maintain steady antibiotic levels for optimal effectiveness.
Symptoms of overdose may include severe nausea, vomiting, diarrhea, dizziness, agitation, or seizures—particularly in patients with kidney impairment. If an overdose is suspected, seek urgent medical care or contact your local poison control center immediately. Management is supportive; adequate hydration and airway protection are prioritized, and anticonvulsants may be used if needed. Cephalexin is dialyzable, so hemodialysis can enhance elimination in severe cases, especially with renal dysfunction.
Store Cephadex capsules at room temperature (generally 20–25°C/68–77°F), away from excess heat and moisture. Keep in the original, tightly closed container. For reconstituted oral suspension, refrigerate (2–8°C/36–46°F), shake well before each dose, and discard any unused portion after 14 days. Do not freeze the suspension. Keep all medications out of reach of children and pets.
In the United States, cephalexin (the active ingredient in Cephadex) is an FDA‑approved prescription medication. Federal and state laws require a valid prescription from a licensed prescriber after a clinical evaluation. Buying antibiotics without a prescription or using leftover antibiotics is unsafe and may be illegal. It also contributes to antibiotic resistance and can delay appropriate care if your infection requires a different treatment.
HealthSouth Rehabilitation Hospital of Las Vegas provides a legal, structured pathway to access Cephadex: a streamlined online intake is reviewed by a licensed clinician who can determine whether cephalexin is appropriate for your condition. If clinically indicated, an electronic prescription is issued and filled by the pharmacy with pharmacist counseling, clear dosing instructions, and follow‑up support. This telehealth‑enabled process preserves antibiotic stewardship and regulatory compliance while offering the convenience of home delivery and transparent pricing—without asking you to navigate in‑person visits when a virtual evaluation is suitable.
Cephadex is a brand name for cephalexin, a first-generation cephalosporin antibiotic. It kills susceptible bacteria by disrupting cell wall synthesis, making it effective against many gram-positive organisms and some gram-negative bacteria.
Clinicians commonly prescribe Cephadex for skin and soft tissue infections (like cellulitis and impetigo), uncomplicated urinary tract infections, streptococcal throat infections, and certain dental infections. Use is guided by local resistance patterns and culture results when available.
Many people notice improvement within 24–48 hours, though full recovery depends on the infection and individual factors. Keep taking it for the full prescribed course even if you feel better to prevent relapse and resistance.
No. Cephadex works only against bacterial infections and does not treat viruses such as the common cold, influenza, or COVID-19.
Take doses at evenly spaced times as prescribed; with or without food is acceptable, but food can reduce stomach upset. Swallow capsules with water, measure liquid carefully, and don’t skip or stop early unless your clinician advises.
Nausea, diarrhea, abdominal discomfort, headache, and rash are the most reported. Yeast infections (thrush or vaginal candidiasis) can occur due to disruption of normal flora.
Seek immediate help for signs of severe allergy (hives, wheeze, facial swelling, trouble breathing), severe or bloody diarrhea with cramping (possible C. difficile colitis), widespread blistering rash, or yellowing of skin/eyes.
Avoid if you’ve had a serious immediate allergy to cephalosporins; use caution with a history of anaphylaxis to penicillins. People with significant kidney impairment, prior C. difficile infection, or multiple antibiotic allergies need individualized guidance and possible dose adjustments.
Cephalexin is generally considered safe in pregnancy and compatible with breastfeeding. Small amounts pass into breast milk; monitor infants for loose stools or thrush and discuss any concerns with your clinician.
Notable interactions include probenecid (raises cephalexin levels), warfarin (may increase bleeding risk/INR), and metformin (levels may rise; monitor glucose). Oral live typhoid vaccine effectiveness is reduced while on antibiotics; otherwise there are no major food restrictions.
Alcohol does not have a known direct interaction with cephalexin, but it can worsen side effects like stomach upset or dizziness. Moderate intake is generally acceptable unless your clinician advises otherwise.
Take it as soon as you remember unless it’s close to the next scheduled dose. Do not double up; resume your regular schedule.
Duration varies by infection, often 5–7 days and sometimes up to 10 or more. Follow the prescribed course and check back if symptoms aren’t improving in 48–72 hours.
Yes, cephalexin is widely used in pediatrics with weight-based dosing. A flavored suspension is available; use an accurate measuring device and follow the prescribed schedule.
Cephalexin can cause false-positive urine glucose with some copper-reduction tests and a positive direct Coombs test. It does not reduce hormonal contraceptive effectiveness, but vomiting or severe diarrhea can impair pill absorption; use backup if that occurs.
Store capsules at room temperature away from moisture. Most cephalexin suspensions are kept refrigerated and discarded after 14 days—follow your pharmacy label.
If symptoms worsen or fail to improve within 48–72 hours, contact your clinician. You may need culture-guided therapy, a broader-spectrum cephalosporin, or evaluation for nonbacterial or resistant infections.
Any antibiotic can disrupt normal flora and predispose to thrush or vaginal yeast infections. Report persistent itching, discharge, or mouth sores so your clinician can recommend appropriate treatment.
Drowsiness is uncommon; most people do not experience impaired alertness. If you feel dizzy or unwell, avoid driving or operating machinery until you feel better.
No, cephalexin typically does not cover MRSA. Your clinician will choose an alternative agent if MRSA is suspected or confirmed.
Keflex is another brand of cephalexin; both contain the same active ingredient and work the same way. Choice usually depends on availability, cost, and local branding.
Both are first-generation cephalosporins with similar coverage for skin infections and uncomplicated UTIs. Cefadroxil has a longer half-life, allowing once- or twice-daily dosing, which may aid adherence; clinical outcomes are otherwise comparable when the organism is susceptible.
Cefuroxime (a second-generation cephalosporin) offers better coverage of H. influenzae and M. catarrhalis, making it common in sinusitis and some respiratory infections. Cephalexin often provides stronger activity against MSSA and streptococci in skin and soft tissue infections.
Cefixime (third-generation) has broader gram-negative activity but weaker staphylococcal and streptococcal coverage than cephalexin. Clinicians may prefer cefixime for certain urinary or gastrointestinal pathogens, while cephalexin is favored for many skin infections.
Cefdinir provides better coverage of common respiratory pathogens than cephalexin but is less reliable for MSSA skin infections. Cefdinir can interact with iron, causing reddish stools and reduced absorption; both can cause diarrhea.
Cefpodoxime (third-generation oral) improves coverage of beta-lactamase–producing respiratory pathogens and is often used for community-acquired pneumonia or sinusitis. Cephalexin is typically chosen for nonpurulent cellulitis and other skin infections due to strong gram-positive activity.
Both are older oral cephalosporins; cefaclor (second-generation) has been linked to serum sickness–like reactions in some patients. Spectrum differences exist, but selection today is more often driven by availability, tolerability, and local guidelines.
Cefazolin is an injectable first-generation cephalosporin used in hospitals for surgical prophylaxis and moderate-to-severe MSSA infections. Cephalexin is the oral agent often used for mild infections or as step-down therapy when patients are stable.
Ceftriaxone (third-generation, injectable) is broader-spectrum and longer-acting, used for more serious infections like severe pneumonia or complicated UTIs. Cephalexin is appropriate for mild-to-moderate outpatient infections in susceptible bacteria.
Ceftibuten (third-generation oral) emphasizes gram-negative coverage and is used for some otitis media and bronchitis cases, but it has limited staphylococcal activity. Cephalexin remains preferred for many skin infections due to better MSSA and streptococcal coverage.
No. Ceftazidime (third-generation IV) targets difficult gram-negative organisms, including Pseudomonas, and has relatively weak activity against MSSA. Cephalexin is for common outpatient gram-positive infections and some uncomplicated gram-negative UTIs.
Ceftaroline (fifth-generation) covers MRSA as well as many streptococci and some gram-negatives. Cephalexin does not cover MRSA; ceftaroline is reserved for specific, often more serious infections under specialist guidance.
Cefprozil (second-generation) extends coverage to some beta-lactamase–producing respiratory pathogens and is used in sinusitis or otitis media. Cephalexin is often preferred for uncomplicated skin infections; the “better” choice depends on the site of infection and likely bacteria.
Both can treat susceptible UTIs, but local resistance patterns drive choice. Cefpodoxime may retain activity against some beta-lactamase–producing organisms; cephalexin remains effective for many uncomplicated cases when susceptibility is confirmed.
Cephadex is a brand; generic cephalexin contains the same active ingredient and is bioequivalent when approved by regulators. Differences are typically in price, fillers, and branding rather than clinical effect.
Cefuroxime is often favored for bacterial sinusitis because of better activity against H. influenzae and M. catarrhalis. Cephalexin is not usually first-line for sinusitis unless guided by culture or specific clinical scenarios.